Examining Health Care Denials and Delays in Medicare Advantage
Comparison of Average Sales Prices and Average Manufacturer Prices: Results for the Fourth Quarter of 2022
Review of the Department of Health and Human Services Compliance with the Federal Information Security Modernization Act of 2014 for Fiscal Year 2022
Medicare Improperly Paid Providers for Some Psychotherapy Services, Including Those Provided via Telehealth, During the First Year of the COVID-19 Public Health Emergency
Medicare Could Have Saved Up To $128 Million Over 5 Years if CMS Had Implemented Controls To Address Duplicate Payments for Services Provided to Individuals With Medicare and Veterans Health Administration Benefits
Toolkit: Analyzing Telehealth Claims to Assess Program Integrity Risks
Modification of Advisory Opinion 20-04
Medicare Advantage Compliance Audit of Specific Diagnosis Codes That HumanaChoice (Contract H6609) Submitted to CMS
Testimony of Christi A. Grimm
CMS Did Not Accurately Report on Care Compare One or More Deficiencies Related to Health, Fire Safety, and Emergency Preparedness for an Estimated Two-Thirds of Nursing Homes
Texas Could Not Support the Permissibility of the Funds Used as the State Share of the Medicaid Delivery System Reform Incentive Payment Program
Medicare Advantage Compliance Audit of Specific Diagnosis Codes That Cigna-HealthSpring Life & Health Insurance Company, Inc. (Contract H4513) Submitted to CMS
Advisory Opinion 23-03
Medicare Advantage Compliance Audit of Specific Diagnosis Codes That MCS Advantage, Inc. (Contract H5577) Submitted to CMS
Maryland Child Support Administration Generally Claimed Administrative Costs That Were Allowable and Allocable
Medicare Improperly Paid Physicians an Estimated $30 Million for Spinal Facet-Joint Interventions
The District of Columbia Has Taken Significant Steps To Ensure Accountability Over Amounts Managed Care Organizations Paid to Pharmacy Benefit Managers
Medicare Advantage Compliance Audit of Specific Diagnosis Codes That Geisinger Health Plan (Contract H3954) Submitted to CMS
Georgia Did Not Always Invoice Rebates to Manufacturers for Pharmacy and Physician-Administered Drugs
Some Skin Substitute Manufacturers Did Not Comply with New ASP Reporting Requirements